A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study. A single dose of ...
Kenya marked yet another significant milestone in its quest to address age-old preventable diseases that continue to place a significant burden on the country's healthcare system. On Friday July 5, ...
A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by ...